Abstract
DAK is supported by an MB PhD Award from the International Journal of Experimental Pathology. AJN is funded by Parkinson’s UK (ref G1606) and the Barts Charity (Preventive Neurology Unit). GDS and DAL work in a unit that receives funding from the University of Bristol and the UK Medical Research Council (MC_UU_1201/1 and MC_UU_1201/5). DAL is a National Institute of Health Research Senior Investigator (NF-SI-0166-10196). MN, AS and AN participation in this study was supported in part by the Intramural Research Program of the National Institute on Aging, NIH. University College London Hospitals and University College London receive support from the Department of Health's National Institute for Health Research (NIHR) Biomedical Research Centres (BRC). NWW is an NIHR senior Investigator and receives support from the JPND-MRC COmprehensive Unbiased Risk factor Assessment for Genetics and Environment in Parkinson’s disease (COURAGE).
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
